2004
DOI: 10.1016/j.bbr.2004.01.016
|View full text |Cite
|
Sign up to set email alerts
|

A chronic Alzheimer’s model evoked by mitochondrial poison sodium azide for pharmacological investigations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
52
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 78 publications
(54 citation statements)
references
References 34 publications
2
52
0
Order By: Relevance
“…Rats with excitotoxic lesions in the PCC were not different than control animals in a sucrose consumption test (Bussey et al, 1996). Also, previous studies have shown that rats treated systemically with sodium azide have no change in sensory or motor function, or in exploratory activity in an open field chamber (Bennett and Rose, 1992;Szabados et al, 2004). However, they did have impaired memory for spatial tasks such as the eight-arm radial maze (Bennett and Rose, 1992), Morris water maze , and holeboard task (Callaway et al, 2002).…”
Section: Discussionmentioning
confidence: 93%
“…Rats with excitotoxic lesions in the PCC were not different than control animals in a sucrose consumption test (Bussey et al, 1996). Also, previous studies have shown that rats treated systemically with sodium azide have no change in sensory or motor function, or in exploratory activity in an open field chamber (Bennett and Rose, 1992;Szabados et al, 2004). However, they did have impaired memory for spatial tasks such as the eight-arm radial maze (Bennett and Rose, 1992), Morris water maze , and holeboard task (Callaway et al, 2002).…”
Section: Discussionmentioning
confidence: 93%
“…Azide has been used in the development of models of chronic Alzheimer's disease and amyotrophic lateral sclerosis (ALS) (Kaal et al, 2000;Szabados et al, 2004). Sodium azide administered to rats at 45 mg/kg/day caused both cognitive deficits and histopathological changes similar to changes caused by Alzheimer's disease (Szabados et al, 2004), while the administration of up to 100 μM azide caused dose dependent death in motoneurons (Kaal et al, 2000). A concentration of 30 μM was lethal to motoneurons as compared to the survival of 44% of interneurons at the same concentration (Kaal et al, 2000).…”
Section: 14mentioning
confidence: 99%
“…Similarly, sodium azide (NaN 3 ) is a substance that is acutely neurotoxic [11] . Several studies conducted on its biological interaction with the central nervous system established it as a consistent and potent neurotoxin [12][13][14] . Selectively reduced complex IV activity is a pathogenic feature of postmortem AD brains and the inhibition of this complex could be evoked by the chronic administration of NaN 3 in animals [14] .…”
Section: Introductionmentioning
confidence: 99%
“…Several studies conducted on its biological interaction with the central nervous system established it as a consistent and potent neurotoxin [12][13][14] . Selectively reduced complex IV activity is a pathogenic feature of postmortem AD brains and the inhibition of this complex could be evoked by the chronic administration of NaN 3 in animals [14] . Partial inhibition of the mitochondrial respiratory chain produces free radicals, diminishes aerobic energy metabolism and causes excitotoxic damage that creates a deleterious spiral leading to neurodegeneration [15] .…”
Section: Introductionmentioning
confidence: 99%